Clinical Trial Update: Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction [Phase 3]

View source ↗

Summary

This clinical trial update indicates that a Phase 3 study of omecamtiv mecarbil (CK-1827452) for chronic heart failure with severely reduced ejection fraction i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• omecamtiv mecarbil (omecamtiv mecarbil)

Snippet

Sponsor: Cytokinetics | Conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction | Phase 3 | Status: RECRUITING